Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

In Vitro Diagnostics Markets Grow at Double the Pace of Pharma Markets in Shift toward Globalization

March 7, 2013 8:04 am | by PR Newswire | News | Comments

Global in vitro diagnostics markets are a bright spot in the healthcare industry largely due to the increasing focus on global expansion. This is particularly seen in emerging markets that continue to gain steam as markets flatten. This briefing, featuring a live Q&A with the industry analyst, will explore the IVD market dynamics in these and other key regions globally.

Clinical Trial Results for Dune Medical Devices' MarginProbe@ System Presented at 66th Annual SSO Cancer Symposium

March 7, 2013 8:01 am | by The Associated Press | News | Comments

Dune Medical Devices, Inc., announced today that results from the pivotal clinical trial for the MarginProbe System, Dune's breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, were presented at the 66th Annual Society of Surgical Oncology (SSO) Cancer ...

HD Medical, Inc. Launches US Business Operations

March 6, 2013 8:05 am | by The Associated Press | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Mar 6, 2013--At ACC.13, HD Medical Inc. a recently formed medical device research and development innovator headquartered in Santa Clara, CA, today announces the launch of US business operations. This new company is delivering revolutionary diagnostic technologies...

Advertisement

Appointment of Dr. Ian Gilham as Chairman of the Board

March 5, 2013 2:23 pm | by Bio-Medicine.Org | News | Comments

LISBON, Portugal , March 5, 2013 /- Biosurfit, a rapidly-growing company focused on the Point of Care medical diagnostic market, is pleased to announce today the appointment of Dr. Ian Gilham as Chairman of the Board. Previously, Dr. Ian Gilham was Chief Executive Officer of Axis-Shield plc, the in-vitro diagnostics company acquired by Alere in November 2011 for £...

AgPlus Diagnostics Unveils First Working Prototype of Handheld, Rapid, On-the-Spot Diagnostic System

March 5, 2013 12:01 pm | by AgPlus Diagnostics | News | Comments

AgPlus Diagnostics is pleased to announce that the first functional prototype of the handheld AgPlus Diagnostics analytical platform is now fully operational and available for demonstration. Delivering laboratory-grade, quantifiable results within just 10 minutes of sample application, the portable AgPlus technology system has enormous potential in a wide variety of applications.

Welch Allyn Will Showcase the EarlySense Contact-Free Patient Monitoring and Electronic Vitals Documentation Systems at HIMSS13

March 4, 2013 10:24 am | by Welch Allyn | News | Comments

Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, will showcase the EarlySense Vitals Surveillance System at the Healthcare Information and Management Systems Society (HIMSS) trade show this week at the Ernest N. Morial Convention Center in New Orleans.

FDA Clears Philips' MicroDose SI Mammography System

March 4, 2013 9:29 am | by Mass Device | News | Comments

Technology giant Philips won FDA clearance for its MicroDose SI full-field mammography system, which the company hopes to leverage as a platform new mammogram imaging applications. The system promises reduced radiation dosages in producing high quality images, 5-minute exam times and ergonomic design with curved and warmed breast support.

Larry Cohen Appointed CEO of Exalenz Bioscience

March 4, 2013 8:30 am | by The Associated Press | News | Comments

MODIIN, Israel--(BUSINESS WIRE)--Mar 4, 2013--Exalenz Bioscience (TASE: EXEN), a developer of a unique medical device intended for the diagnostics and management of disease of the digestive tract and the liver, has reported today the appointment of Larry Cohen as the company's CEO.

Advertisement

Virtua and Alere Form Alliance for Care Coordination

March 4, 2013 8:01 am | by The Associated Press | News | Comments

Virtua, a healthcare delivery leader in southern New Jersey, and Alere Inc. (NYSE: ALR), a global leader in health information solutions, announced today a strategic alliance to provide health information systems and home-based, biometric monitoring devices to support care coordination ...

Doctors Can Detect Skin Cancer Earlier With New Modernizing Medicine and 3Gen, Inc. Partnership

March 1, 2013 9:03 am | by The Associated Press | News | Comments

Modernizing Medicine, the creator of the Electronic Medical Assistant™ (EMA), a cloud-based specialty-specific electronic medical records (EMR) system, announced today that it has partnered with 3Gen, Inc., a product design and development company which...

Santech, Inc. joins Qualcomm Life’s 2net Ecosystem

March 1, 2013 9:00 am | by The Associated Press | News | Comments

SAN DIEGO--(BUSINESS WIRE)--Mar 1, 2013--Santech, Inc. has integrated its mobile messaging platform, SanText®, to the 2net ™ Platform and Hub, designed with attention to HIPAA privacy and security requirements, and leveraging the cloud-based platform for biometric sensor data operated by Qualcomm...

OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa

March 1, 2013 8:16 am | by The Associated Press | News | Comments

MIAMI--(BUSINESS WIRE)--Mar 1, 2013--OPKO Health, Inc. (NYSE: OPK) announced that a study published online in Clinical Chemistry, and to be included in the April 2013 print issue, describes the application of OPKO’s point-of-care system to mobile diagnostics, a major advance towards providing...

Philips Receives FDA Clearance to Market MicroDose SI Mammography System

February 28, 2013 2:39 pm | by Bio-Medicine.Org | News | Comments

ANDOVER, Mass. , Feb. 28, 2013 /- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announces 510(k) clearance from the Food and Drug Administration (FDA) for its MicroDose SI system, the first full-field digital mammography (FFDM) system on the market with the capability to enable future Single-Shot Spectral Imaging applications*.

Advertisement

ChartMaxx@ and Appian Announce Partnership to Bring Next Generation Business Process Management to the Healthcare Industry at HIMSS13

February 28, 2013 1:08 pm | by The Associated Press | News | Comments

In line with its reputation for being on the forefront of tools that provide insights for better healthcare, Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced a partnership between ChartMaxx@, its leading Document Management and...

Neuro Kinetics Adds Software, Engineering Professionals as Push Continues for Improved Testing of Battlefield Concussions

February 28, 2013 9:48 am | by The Associated Press | News | Comments

Medical diagnostic device manufacturer Neuro Kinetics, Inc. said today that it has added five software and engineering professionals to its staff as the company continues to develop new testing protocols for diagnosis of concussions and other brain injuries. ...

MEMS devices proliferate in the medical market

February 28, 2013 9:48 am | by Digi-Key Corporation | News | Comments

As the utilization of MEMS continues to grow across various industry sectors, commercial successes like the use of STMicroelectronics’ PCR chips in drug delivery; Boehringer Ingelheim’s success with MEMS-based inhalers; and the microfluidic chips used in Abbott’s blood gas analyzers are helping to drive a growing demand for MEMS devices in the medical market.

T2 Biosystems Announces Patent Covering In Vivo Application of Direct Detection Technology

February 28, 2013 9:00 am | by The Associated Press | News | Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent 8,368,402 (the ‘402 patent), “NMR systems for in vivo detection of analytes”.

Cognoptix begins pre-pivotal clinical trial of its drug/device test designed to identify Alzheimer’s disease via beta amyloid signature in the eyes

February 28, 2013 8:30 am | by The Associated Press | News | Comments

ACTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--Cognoptix announced today that it has begun a 40-patient clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer’s disease patients via a beta amyloid (“Ab”) signature in their eyes. By detecting a specific fluorescent signature of...

NanoString Expands Leadership Team With the Hiring of Two Seasoned Executives

February 28, 2013 7:30 am | by The Associated Press | News | Comments

SEATTLE--(BUSINESS WIRE)--Feb 28, 2013--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Gary S. Riordan as Vice President of Quality and Regulatory Affairs and Kathy...

John Muir Health Pilots Early Warning System For Heart Attack Patients

February 27, 2013 12:58 pm | by The Associated Press | News | Comments

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Feb 27, 2013--Reducing the time it takes heart attack patients to receive treatment significantly increases their chances of survival and minimizes long-term damage to the heart and brain. John Muir Health’s Clinical Research Center recently began a clinical...

Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners

February 26, 2013 9:59 am | by The Associated Press | News | Comments

EDINBURGH, Scotland & NEWTOWN, Pa.--(BUSINESS WIRE)--Feb 26, 2013--Quotient Biodiagnostics (“Quotient”), a global transfusion diagnostics group, is pleased to announce that its shareholders have invested a further $5.0 million in the company. Over the past 18 months Quotient has raised over...

LabCorp Launches Next Generation Sequencing Assay for Familial Cardiac Disease

February 25, 2013 8:45 am | by The Associated Press | News | Comments

BURLINGTON, N.C.--(BUSINESS WIRE)--Feb 25, 2013--Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced it has launched its clinical next generation sequencing assay, GeneSeq®: Cardio for genetic causes of familial cardiac disease. Familial cardiac diseases are...

CardioDx to Present at Cowen and Company 33rd Annual Healthcare Conference

February 25, 2013 8:30 am | by The Associated Press | News | Comments

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the Cowen and Company 33rd Annual Healthcare Conference on Monday, March 4, 2013 at 10:00 a.m. ET at the Boston Marriott Copley Place in Boston.

Atossa Genetics Receives Warning Letter From the Food and Drug Administration

February 25, 2013 8:30 am | by The Associated Press | News | Comments

SEATTLE--(BUSINESS WIRE)--Feb 25, 2013--Atossa Genetics, Inc. (NASDAQ: ATOS) (“Atossa” or the “Company”) received a Warning Letter (“Letter”) from the FDA on February 21, 2013, regarding its Mammary Aspirate Specimen Cytology Test (MASCT) System and MASCT System Collection Test (together, the...

Lab21 and IntegraGen Partner to Develop New Colorectal Cancer Diagnostic

February 22, 2013 5:09 am | by The Associated Press | News | Comments

CAMBRIDGE, England--(BUSINESS WIRE)--Feb 22, 2013--Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading